|Bid||0.4000 x 0|
|Ask||0.4050 x 0|
|Day's Range||0.3900 - 0.4050|
|52 Week Range||0.3000 - 1.2000|
|Beta (5Y Monthly)||1.99|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 01, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.20|
Laicization of Brian BoucherMONTREAL, Oct. 23, 2020 /CNW Telbec/ - The Honourable Pepita G.
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a medical cannabis leader with core operations in Latin America and Europe announced the appointment, effective October 16, of Joel Friedman as CFO following the resignation of Wendy Kaufman, the Company's CFO since July, 2019. Ms. Kaufman is departing to return to the mining industry where she has spent the greater part of her executive career.
LÉVIS, QC, Oct. 16, 2020 /CNW Telbec/ - Desjardins Group is proud to announce the establishment of the Aequitas fund, a private investment fund focused on impact finance which will be used to promote gender equality, combat climate change and contribute to achieving other Sustainable Development Goals (SDGs) through financial inclusion.